GLP-3 + Cagrilintide research peptide blend is not approved for human consumption, medical use, or therapeutic application
Recent approvals of the medication specifically for weight management have opened up a huge new group of patients
We follow these rules to make sure the plasma donation journey is safe and sound for both our donors and our patients who rely on plasma-derived medicines
2 3 4 5 6 7 Mounjaro (tirzepatide) KwikPen Summary of Product Characteristics, sections 4.4 and 4.8, MHRA/emc: The incidence of nausea, diarrhoea and vomiting occurred primarily during dose escalation and decreased over time. 2 Ozempic (semaglutide) 0.5 mg Summary of Product Characteristics, section 4.8, MHRA/emc: Nausea occurred in 17% and 19.9% of patients when treated with semaglutide 0.5 mg and 1 mg, respectively Most events were mild to moderate in severity and of short duration
Wegovy was released in mid-2023, and is exactly the same active ingredient as Ozempic